News About: Pharm. Industry
Drug makers may spend 20% of revenue on R&D
Cleanup drive to sweep the local pharmaceutical industry will give drug makers an opportunity to invest the money saved from the elimination of illegal rebates into research and development by 20 percent, according to...
Sanofi-Aventis to strengthen R&D in Korea
Sanofi-Aventis, a France-based pharmaceutical company, plans to strengthen research and development (R&D) capability in Korea in cooperation with local research institutes to step up studies in major fields of medicin...
Bayer Schering holds cardiovascular risk management symposium
The third Crdiovascular Risk Management Symposium Asia-Pacific 2009 was held in Grand Intercontinental Hotel in Seoul, entitled “Improving Cardiovascular Disease Outcomes Through Integrated Management”, Bayer Schering...
Green Cross, LegoChem Bioscience expand cooperation
Cooperation between Green Cross Corporation and LegoChem Bioscience, a local biopharmaceutical firm, is picking up, with efforts being made to step up joint collaboration in the areas of development and commercializat...
Dong-A to expand share in mouthwashes market
Dong-A Pharm said on June 4 it has launched a series of mouthwash products containing cetylpyridinium chloride (CPC) plus sodium fluorinate as part of efforts to strengthen its presence in the growing dental care mark...
KFDA mulls leniency on 120 pharmaceutical firms
The Korea Food and Drug Administration is unlikely to filed a complaint against 120 drugmakers who produced 122 drugs and medical goods confirmed to have used talc contaminated with asbestos last April.
In a briefi...
10 leading drugmakers pledge joint action against rebate
The domestic major pharmaceutical firms pledged on June 4 to root out the so-called rebate, according to pharmaceutical sources.
The meeting between presidents of ten pharmaceutical firms took place after Auh June-...
Pharmaceutical firms urged to nurture human resources management
Pharmaceutical company will need to re-establish human resources management instead of more sales growth, as rebate and other irregular trading activities have tainted the drugmakers’ image in the recent months, accor...
Park named Johnson & Johnson North Asia chief
Johnson & Johnson Medical Korea announced that Park Se-yeol, incumbent president of the company, was named as North East leader of Johnson & Johnson effective June 1.
Park will be responsible for medical business a...
KPMA president caught bribing doctors
Auh June-sun, president of the Korea Pharmaceutical Manufacturers Association and chairman of Ahngook Pharm, is under fire for having provided illegal kickbacks to doctors in exchange for prescribing his products.
...
